ArticleClinical, cosmetic and investigational dermatology2025
Association of the Monocyte-to-High Density Lipoprotein Ratio with the FRS and as a Predictor of Cardiovascular Risk in Individuals with Psoriasis Vulgaris.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hematological inflammatory markers as predictors of atherosclerotic progression in patients with psoriasis: A retrospective case-control study from the SH-YIMED database.JID innovations : skin science from molecules to population health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The monocyte-to-high-density lipoprotein ratio (MHR) has emerged as a novel inflammatory biomarker associated with cardiovascular diseases (CVDs). This retrospective study aimed to investigate the relationship between MHR and the Framingham risk score (FRS) and assess the prognostic significance of this relationship for mid- to high-risk CVD in individuals with psoriasis vulgaris (PsV). Methods: A total of 128 PsV patients and 120 healthy controls were included. The neutrophil-to-high-density lipoprotein ratio (NHR), MHR, and neutrophil-to-lymphocyte ratio (NLR) were assessed and compared between the two groups. Correlations between MHR and FRS were evaluated. Results: PsV patients with intermediate to high cardiovascular risk exhibited significantly higher NHR, MHR, and NLR compared to controls (p = 0.018, p = 0.002, p < 0.001, respectively). Furthermore, FRS was positively correlated with MHR, NHR, and NLR in the PsV patients (r=0.27, p = 0.002; r=0.21, p = 0.017 and r=0.33, p < 0.001, respectively). Logistic regression analysis identified age, sex, and the MHR as influencing factors for the FRS (p < 0.05). Receiver operating characteristic (ROC) curve analysis revealed that the highest Youden's index (0.316) was obtained at an MHR of 0.24, with sensitivity, specificity, and area under the ROC curve of 0.729, 0.587, and 0.662 (95% CI of 0.565, 0.758), respectively. Conclusion: MHR was significantly associated with FRS, which may serve as a valuable predictor of medium to high risk of CVDs in patients with PsV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.